153 related articles for article (PubMed ID: 25234024)
1. Biochemical cure after reoperations for medullary thyroid carcinoma: a meta-analysis.
Rowland KJ; Jin LX; Moley JF
Ann Surg Oncol; 2015 Jan; 22(1):96-102. PubMed ID: 25234024
[TBL] [Abstract][Full Text] [Related]
2. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
3. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
Gimm O; Ukkat J; Dralle H
World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of reoperations for medullary thyroid carcinoma.
Fialkowski E; DeBenedetti M; Moley J
World J Surg; 2008 May; 32(5):754-65. PubMed ID: 18188643
[TBL] [Abstract][Full Text] [Related]
5. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
6. Surgical strategy for the treatment of medullary thyroid carcinoma.
Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
[TBL] [Abstract][Full Text] [Related]
7. Benefit-risk balance of reoperation for persistent medullary thyroid cancer.
Machens A; Dralle H
Ann Surg; 2013 Apr; 257(4):751-7. PubMed ID: 23023200
[TBL] [Abstract][Full Text] [Related]
8. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336
[TBL] [Abstract][Full Text] [Related]
9. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
10. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
11. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
Machens A; Dralle H
J Clin Endocrinol Metab; 2010 Jun; 95(6):2655-63. PubMed ID: 20339026
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of sporadic medullary thyroid cancer.
Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
[TBL] [Abstract][Full Text] [Related]
13. Chasing calcitonin: reoperations for medullary thyroid carcinoma.
Balentine CJ; Chen H
Ann Surg Oncol; 2015 Jan; 22(1):7-8. PubMed ID: 25249261
[No Abstract] [Full Text] [Related]
14. Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.
Pilaete K; Delaere P; Decallonne B; Bex M; Hauben E; Nuyts S; Clement P; Hermans R; Vander Poorten V
B-ENT; 2012; 8(2):113-21. PubMed ID: 22896930
[TBL] [Abstract][Full Text] [Related]
15. Frequency and significance of cervicomediastinal lymph node metastases in medullary thyroid carcinoma: results of a compartment-oriented microdissection method.
Dralle H; Damm I; Scheumann GF; Kotzerke J; Kupsch E
Henry Ford Hosp Med J; 1992; 40(3-4):264-7. PubMed ID: 1362420
[TBL] [Abstract][Full Text] [Related]
16. Medullary thyroid carcinoma: management of lymph node metastases.
Moley JF
J Natl Compr Canc Netw; 2010 May; 8(5):549-56. PubMed ID: 20495084
[TBL] [Abstract][Full Text] [Related]
17. Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening.
Machens A; Dralle H
Eur J Endocrinol; 2016 Sep; 175(3):219-28. PubMed ID: 27334331
[TBL] [Abstract][Full Text] [Related]
18. Reoperation for recurrent or persistent medullary thyroid cancer.
Moley JF; Wells SA; Dilley WG; Tisell LE
Surgery; 1993 Dec; 114(6):1090-5; discussion 1095-6. PubMed ID: 8256212
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma--update and present management controversies.
Al-Rawi M; Wheeler MH
Ann R Coll Surg Engl; 2006 Sep; 88(5):433-8. PubMed ID: 17002842
[TBL] [Abstract][Full Text] [Related]
20. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
